QUANTUM GENOMICS: Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH
Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing